Si-Bone (SIBN) Change in Accured Expenses (2017 - 2026)
Si-Bone's (SIBN) quarterly Change in Accured Expenses came in at -$5.6 million in Q1 2026, down 27.43% year-on-year from -$7.8 million in Q1 2025, and down 367.81% quarter-over-quarter from $2.1 million in Q4 2025.
Si-Bone (SIBN) Change in Accured Expenses (2017 - 2026) Analysis & Trends
Si-Bone's Change in Accured Expenses history runs 10 years deep, the most recent figure standing at -$5.6 million for Q1 2026.
- On a quarterly basis, Change in Accured Expenses fell 27.43% year-over-year to -$5.6 million in Q1 2026; TTM through Mar 2026 was -$1.0 million, a 132.9% decrease from a year earlier, with the FY2025 full-year figure at $179000.0, down 90.62% from the prior year.
- Change in Accured Expenses retreated to -$5.6 million in Q1 2026 per SIBN's latest filing, from $2.1 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $3.9 million in Q4 2023 and bottomed at -$5.7 million in Q1 2024.
- The 5-year median for Change in Accured Expenses is $1.1 million (2022), against an average of $90705.9.
- Across the five-year window, Change in Accured Expenses slumped 63.03% in 2022 and jumped 189.03% in 2023, its largest moves.
- Year by year, Change in Accured Expenses stood at $2.3 million in 2022, then surged by 68.09% to $3.9 million in 2023, then slipped by 14.13% to $3.3 million in 2024, then tumbled by 36.39% to $2.1 million in 2025, then slumped by 367.81% to -$5.6 million in 2026.
- Per Business Quant, the three latest SIBN Change in Accured Expenses figures stand at -$5.6 million (Q1 2026), $2.1 million (Q4 2025), and $1.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn | -347.10 Mn |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn | -250.00 Mn |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 145.10 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn | 21.07 Mn |
| 10 | Si-Bone | 753.03 Mn | 608.35 Mn | 41.94 Mn | -5.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.64 Mn |
| Mar 31, 2026 | -5.64 Mn |
| Dec 31, 2025 | 2.11 Mn |
| Dec 31, 2025 | 2.11 Mn |
| Sep 30, 2025 | 1.54 Mn |
| Sep 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 962,000.00 |
| Jun 30, 2025 | 962,000.00 |
| Mar 31, 2025 | -4.43 Mn |
| Mar 31, 2025 | -4.43 Mn |
| Dec 31, 2024 | 3.31 Mn |
| Dec 31, 2024 | 3.31 Mn |
| Sep 30, 2024 | 2.55 Mn |
| Sep 30, 2024 | 2.55 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Mar 31, 2024 | -5.66 Mn |
| Mar 31, 2024 | -5.66 Mn |
| Dec 31, 2023 | 3.86 Mn |
| Dec 31, 2023 | 3.86 Mn |